14m
US approves oral drug for adults with rare type of lung cancer after early clinical trials globally
Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at straitstimes.com. Read more at straitstimes.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback